NO306447B1 - Anvendelse av kolinerg substans for behandling av törre öyne - Google Patents

Anvendelse av kolinerg substans for behandling av törre öyne

Info

Publication number
NO306447B1
NO306447B1 NO940400A NO940400A NO306447B1 NO 306447 B1 NO306447 B1 NO 306447B1 NO 940400 A NO940400 A NO 940400A NO 940400 A NO940400 A NO 940400A NO 306447 B1 NO306447 B1 NO 306447B1
Authority
NO
Norway
Prior art keywords
treatment
dry eyes
cholinergic
substance
cholinergic substance
Prior art date
Application number
NO940400A
Other languages
English (en)
Norwegian (no)
Other versions
NO940400L (no
NO940400D0 (no
Inventor
Rudolph Wolfgang Hahnenberger
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO940400L publication Critical patent/NO940400L/no
Publication of NO940400D0 publication Critical patent/NO940400D0/no
Publication of NO306447B1 publication Critical patent/NO306447B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO940400A 1991-08-13 1994-02-07 Anvendelse av kolinerg substans for behandling av törre öyne NO306447B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9102340A SE9102340D0 (sv) 1991-08-13 1991-08-13 Pharmaceutical composition containing carbachol and othercholinergic substances
PCT/SE1992/000542 WO1993003718A1 (fr) 1991-08-13 1992-08-07 Composition pharmaceutique contenant du carbachol et d'autres substances cholinergiques

Publications (3)

Publication Number Publication Date
NO940400L NO940400L (no) 1994-02-07
NO940400D0 NO940400D0 (no) 1994-02-07
NO306447B1 true NO306447B1 (no) 1999-11-08

Family

ID=20383456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940400A NO306447B1 (no) 1991-08-13 1994-02-07 Anvendelse av kolinerg substans for behandling av törre öyne

Country Status (14)

Country Link
US (1) US5679713A (fr)
EP (2) EP0528776A1 (fr)
JP (1) JPH06509801A (fr)
AT (1) ATE172114T1 (fr)
AU (1) AU671805B2 (fr)
CA (1) CA2114239C (fr)
DE (1) DE69227324T2 (fr)
DK (1) DK0661968T3 (fr)
ES (1) ES2123005T3 (fr)
FI (1) FI108516B (fr)
HU (1) HU221592B (fr)
NO (1) NO306447B1 (fr)
SE (1) SE9102340D0 (fr)
WO (1) WO1993003718A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250927A3 (fr) * 1997-02-24 2003-03-26 S.L.A. Pharma AG Composition pharmaceutique comprenant de la nifedipine pour application topique
JP2001513495A (ja) * 1997-08-08 2001-09-04 デューク ユニバーシティ 外科的処置を容易にする組成物、装置および方法
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
DK2498771T3 (da) 2009-11-12 2014-01-27 Acacia Pharma Ltd Anvendelse af bethanechol til behandling af xerostomi
AR104177A1 (es) * 2015-04-03 2017-07-05 Santen Pharmaceutical Co Ltd Sistema para la administración de fármacos en la glándula lagrimal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185220A (en) * 1938-08-17 1940-01-02 Smith Kline French Lab Medicinal agent
GB1386864A (en) * 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム

Also Published As

Publication number Publication date
FI940637A (fi) 1994-02-11
US5679713A (en) 1997-10-21
EP0661968A1 (fr) 1995-07-12
EP0661968B1 (fr) 1998-10-14
DE69227324T2 (de) 1999-04-29
HU221592B (hu) 2002-11-28
CA2114239A1 (fr) 1993-02-14
ATE172114T1 (de) 1998-10-15
JPH06509801A (ja) 1994-11-02
AU2463192A (en) 1993-03-16
AU671805B2 (en) 1996-09-12
ES2123005T3 (es) 1999-01-01
SE9102340D0 (sv) 1991-08-13
HUT65946A (en) 1994-08-29
DE69227324D1 (de) 1998-11-19
EP0528776A1 (fr) 1993-02-24
HU9400405D0 (en) 1994-05-30
FI108516B (fi) 2002-02-15
CA2114239C (fr) 2003-10-21
NO940400L (no) 1994-02-07
DK0661968T3 (da) 1999-06-23
NO940400D0 (no) 1994-02-07
FI940637A0 (fi) 1994-02-11
WO1993003718A1 (fr) 1993-03-04

Similar Documents

Publication Publication Date Title
FI905531A0 (fi) Transdermalisk anvaendning av 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobensotiazol.
ATE207342T1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
DE69333775D1 (de) Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
ATE208212T1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
CA2148988A1 (fr) Utilisation d'extraits de bacteries filamenteuses comme agents cosmetiques contre le vieillissement cutane
NO306447B1 (no) Anvendelse av kolinerg substans for behandling av törre öyne
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
DE68917817D1 (de) Verfahren zur Herstellung von vernetzten Polycarbonaten und Zusammensetzungen daraus.
ATE130754T1 (de) Feuchtigkeitsspendende kosmetische zubereitungen.
EP0342565A3 (fr) Utilisation du dérivé thiazole tiprotimod dans la préparation d'un médicament pour le traitement des infections virales
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
ATE122876T1 (de) Stabile kosmetische mittel.
NO890261L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
FR2702768B1 (fr) Nouveaux mono-amides de la Carpaïne, leur préparation et leur application en tant que médicaments.
RU93053043A (ru) Новые производные тиомаринола, способ их получения, фармацевтическая композиция и способ лечения
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції
RU93016580A (ru) Масляная эмульсия для лечения заболеваний кожи и слизистых оболочек
ATE92763T1 (de) Mittel zur behandlung des parkinson-syndroms.